Quality of ambulatory care after myocardial infarction among Medicare patients by type of insurance and region

American Journal of Medicine

Volumn 111, Issue 1, 2001, Pages 24-32

  Seddon, Mary E ^a   Ayanian, John Z ^a,b   Landrum, Mary Beth ^a   Cleary, Paul D ^a   Peterson, Eric A ^d   Gahart, Martin T ^d   McNeil, Barbara J ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Division of General Medicine   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

^d US General Accounting Office   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYPOCHOLESTEROLEMIC AGENT;

ADULT; AGED; AMBULATORY CARE; ARTICLE; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE QUALITY; HEALTH INSURANCE; HEALTH MAINTENANCE ORGANIZATION; HEALTH SURVEY; HEART INFARCTION; HEART REHABILITATION; HUMAN; MALE; MEDICAL FEE; MEDICARE; PRIORITY JOURNAL; UNITED STATES;

ADRENERGIC BETA-ANTAGONISTS; AGED; AMBULATORY CARE; ANTICHOLESTEREMIC AGENTS; ASPIRIN; CALCIUM CHANNEL BLOCKERS; CALIFORNIA; COMORBIDITY; EDUCATIONAL STATUS; ETHNIC GROUPS; FEE-FOR-SERVICE PLANS; FEMALE; FLORIDA; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; INCOME; MALE; MEDICARE; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; NEW ENGLAND; PRESCRIPTIONS, DRUG; QUALITY OF HEALTH CARE; QUESTIONNAIRES; UNITED STATES;

EID: 0034947030     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00741-0     Document Type: Article

References (37)

1. Growth in Medicare managed care enrollment. CYs 1985-96
2. Managed care involvement by cardiovascular specialists: Prevalence, attitudes and influence on practice
3. Managed care performance since 1980
4. The politics of prevention
5. Appropriateness of coronary angiography after myocardial infarction among Medicare beneficiaries. Managed care versus fee for service
6. Geographic variation in the treatment of acute myocardial infarction
7. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected myocardial infarction: ISIS-2
8. Secondary prevention of vascular disease by prolonged antiplatelet treatment
9. A randomized trial of propranolol in patients with acute myocardial infarction. I. Mortality results
10. The Goteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction
11. Timolol-induced reduction in mortality and reinfarction in patients surviving acute myocardial infarction
12. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure
13. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
14. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
15. Cardiac rehabilitation programs. A statement for healthcare professionals from the American Heart Association
16. Cardiac rehabilitation as secondary prevention
17. The effect of diltiazem on mortality and reinfarction after myocardial infarction
18. Calcium channel blockers in acute myocardial infarction and unstable angina: An overview
19. Early administration of nifedipine in suspected acute myocardial infarction: The Secondary Prevention Reinfarction Israeli Nifedipine Trial 2 Study
20. Guidelines for the early management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee to Develop Guidelines for the Early Management of Patients with Acute Myocardial Infarction)
21. Guidelines for the management of patients with acute myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction)
22. Quality of care for Medicare patients with acute myocardial infarction. A four-state pilot study from the Cooperative Cardiovascular Project
23. Improving the quality of care for Medicare patients with acute myocardial infarction
24. National use and effectiveness of β-blockers for the treatment of elderly patients after acute myocardial infarction
25. HMO versus fee-for-service of older persons with acute myocardial infarction
26. Timeliness and quality of care for elderly patients with acute myocardial infarction under health maintenance organization versus fee-for-service insurance
27. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance
28. The exclusion of the elderly and women from clinical trials in acute myocardial infarction
29. Controversies surrounding the use of beta-blockers in older patients with cardiovascular disease
30. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
31. Timolol treatment after myocardial infarction in diabetic patients
32. Beta-blockers for the treatment of hypertension in patients with diabetes: Exploring the contraindication myth
33. Adverse outcomes of underuse of β-blockers in elderly survivors of acute myocardial infarction
34. Quality of care in investor-owned versus not-for-profit HMOs
35. Trust and trustworthy care in the managed care era
36. A conceptual model of the effects of health care organizations on the quality of medical care